Abstract:Yulong Xiong, 1, 2, &ast Zhenhao Zhang, 1, 2, &ast Shangyu Liu, 1, 2 Lishui Shen, 1, 2 Lihui Zheng, 1, 2 Ligang Ding, 1, 2 Limin Liu, 1 Lingmin Wu, 1 Zhicheng Hu, 1 Le Li, 1 Zhao Hu, 1 Zhuxin Zhang, 1 Likun Zhou, 1 Mengtong Xu, 1 Yan Yao 1, 2 1 Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China; 2 State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yan Yao, Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, 167A Beilishi Road, Xi Cheng District, Beijing, 100037, People's Republic of China, Email Introduction: Nanomedicine coated with cell membranes has attracted increasing attention for its enhanced targeting capability and biocompatibility. Based on previous research, we identified interferon regulatory factor 1 (IRF1)-mediated macrophage pyroptosis as a potential therapeutic target for myocarditis. Herein, we fabricated an innovative immune cell membrane-coated zeolitic imidazolate framework-8 (ZIF-8) nano-delivery platform and explored its effects on myocarditis. Methods: ZIF-8 nanoparticles loaded with siRNA targeting IRF1 (siIRF1) were coated with a T lymphocyte-macrophage hybrid membrane (siIRF1@ZIF@HM NPs) via sonication and extrusion. The morphological and biological characteristics of the nanoparticles were evaluated using transmission electron microscopy (TEM) and dynamic light scattering (DLS). Cellular cytotoxicity was assessed by a cell counting kit-8 assay. Cellular uptake and endo-lysosomal escape in M1-differentiated macrophages were visualized via fluorescence microscopy. The targeting specificity and anti-myocarditis effects were evaluated in an experimental autoimmune myocarditis (EAM) mouse model. The anti-pyroptosis effects were assessed by Western blot analysis both in vivo and in vitro. Results: Transcriptional sequencing identified T lymphocytes and macrophages as suitable membrane sources. The ZIF-8 nanoparticles exhibited high siRNA loading capacity and pH responsiveness, enabling an efficient release of siIRF1 from endo-lysosomes to the cytoplasm in macrophages. The hybrid membrane coating enabled specific targeting of M1 macrophages both in vivo and in vitro. Furthermore, delivery of siIRF1 effectively suppressed IRF1 expression and inhibited pyroptosis in IFN-γ-stimulated macrophages. Intravenous injection of siIRF1@ZIF@HM NPs significantly alleviated myocarditis progression without evident side effects. Conclusion: The siIRF1 nanotherapeutic approach shows potential for attenuating myocardial inflammation and mitigating myocarditis progression. Our study highlights the promise of this customized biomimetic nano-delivery system for treating inflammatory diseases. Keywords: hybrid membrane, myocarditis, macrophage, pyroptosis, small interfering RNA, immunotherapy Graphical Myocarditis, characterized by acute inflammatory responses, chronic fibrosis, and cardiac dysfunction, is a pathogenic precursor to ventricular arrhythmias, heart failure, and dilated cardiomyopathy (DCM). 1–3 Despite its increasing prevalence, current therapeutic efficacy remains unsatisfactory. 4–7 This can be attributed to the elusive underlying mechanisms, which result in the lack of effective therapeutic targets to halt the inflammatory cascade in myocarditis. Additionally, systemic drug administration often yields suboptimal drug concentrations at the pathological sites in organ-specific diseases, reducing therapeutic potential and precipitating adverse effects. 8 Consequently, there is an imperative demand for refined strategies that ensure precise targeting and localized intervention. The strategic deployment of small interfering RNA (siRNA) for gene silencing marks a new era in therapeutic interventions for various diseases. 9 However, the crux of siRNA therapy largely depends on identifying an effective target, as this determines the therapeutic efficacy. Pyroptosis is a highly inflammatory form of programmed cell death characterized by cell lysis and release of pro-inflammatory cytokines. 10 Our previo -Abstract Truncated-

Lupeol alleviates autoimmune myocarditis by suppressing macrophage pyroptosis and polarization via PPARα/LACC1/NF-κB signaling pathway

Relationship Between Thinning of Eggshells and Reduction in Number of Eggs Produced after Administration of Some Saluretic Drugs in Domestic Fowls

Periplogenin Inhibits Pyroptosis of Fibroblastic Synoviocytes in Rheumatoid Arthritis Through the NLRP3/Caspase-1/GSDMD Signaling Pathway

Macrophage-T cell hybrid membrane-camouflaged biomimetic nanoparticles ameliorate autoimmune myocarditis via suppressing macrophage pyroptosis by target gene silencing

Empagliflozin alleviates the development of autoimmune myocarditis via inhibiting NF-κB-dependent cardiomyocyte pyroptosis

Peroxisome proliferation-activated receptor-γ ligands ameliorate experimental autoimmune myocarditis

[Peroxisome Proliferation-Activated Receptor-Gamma Ligands Ameliorate Autoimmune Myocarditis Associated with Inhibition of T Cell Immunity].

Puerarin inhibits macrophage M1 polarization by combining STAT1 to reduce myocardial damage in EAM model mice

T Lymphocyte-Macrophage Hybrid Membrane-Coated Biomimetic Nanoparticles Alleviate Myocarditis via Suppressing Pyroptosis by Targeting Gene Silencing

Sinomenine hydrochloride alleviates autoimmune myocarditis via suppressing Th1 cell induced-M1 macrophage pyroptosis

Lupeol protects against cardiac hypertrophy via TLR4-PI3K-Akt-NF-κB pathways

Paeonol interferes with lupus nephritis by regulating M1/M2 polarization of macrophages

Inhibition of Alveolar Macrophage Pyroptosis Reduces Lipopolysaccharide-induced Acute Lung Injury in Mice.

Downregulation of miR-137 Facilitates CD4+ T Cell Pyroptosis in Systemic Lupus Erythematosus via Stimulating AMPK Pathway

Pyroptosis Inhibitors MCC950 and VX-765 Mitigate Myocardial Injury by Alleviating Oxidative Stress, Inflammation, and Apoptosis in Acute Myocardial Hypoxia

In Vivo Remodeling of Altered Autophagy-Lysosomal Pathway by a Phosphopeptide in Lupus

Inhibition of Phosphoglycerate Kinase 1 Attenuates Autoimmune Myocarditis by Reprogramming CD4+ T Cell Metabolism

Blockade of Macrophage Autophagy Ameliorates Activated Lymphocytes-Derived DNA Induced Murine Lupus Possibly Via Inhibition of Proinflammatory Cytokine Production.

Inhibition of Microrna-155 Ameliorates Experimental Autoimmune Myocarditis by Modulating Th17/Treg Immune Response

Cardioprotective Effects Of Peroxisome Proliferator Activated Receptor Gamma Activators On Acute Myocarditis: Anti-Inflammatory Actions Associated With Nuclear Factor Kappa B Blockade

Drp1 Promotes Macrophage M1 Polarization and Inflammatory Response in Autoimmune Myocarditis by Driving Mitochondrial Fission